SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Rojas L.
(Autor externo)

Obras con ISBN:1
Documentos en revistas:42
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:
1.- Immune response in human amebiasis: A protective response? (2015)
 
Documentos en revistas:
1.- Epinephrine and norepinephrine affect the cellular morphology, composition, and structure of Gallibacterium anatis biofilm (2026)
 
2.- THERMO-HYDRAULIC ANALYSIS OF A SMALL MODULAR REACTOR OF TYPE IPWR; (2024)
 
3.- Un modelo stock-flujo ecológico para Centroamérica (2024)
 
4.- Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country (2023)
 
5.- Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study (2023)
 
6.- Prognostic significance of telomerase reverse transcriptase promoter mutations in high grade meningiomas; (2022)
 
7.- Selective Inner Hair Cell Loss in a Neonate Harbor Seal (Phoca vitulina) (2022)
 
8.- Case Report: Differential Genomics and Evolution of a Meningeal Melanoma Treated With Ipilimumab and Nivolumab (2022)
 
9.- KRAS and MET in non-small-cell lung cancer: two of the new kids on the ?drivers? block (2022)
 
10.- p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics (2022)
 
11.- Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question (2022)
 
12.- Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP) (2022)
 
13.- Lung Cancer in Colombia (2022)
 
14.- Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors (2022)
 
15.- Cell-Free Circulating Tumor DNA Improves Standard Genotyping of Non-Small-Cell Lung Cancer and Increases Detection of Targetable Alterations in a Selected Hispanic Cohort (2021)
 
16.- EGFR inhibitors plus bevacizumab are superior than EGFR inhibitors alone as first-line setting in advanced NSCLC with EGFR mutations and BIM deletion polymorphisms (BIM-CLICaP) (2021)
 
17.- Precision oncology in EGFR positive non-small cell lung cancer: Breaking the 10-year barrier-a case report (2021)
 
18.- Genotyping Squamous Cell Lung Carcinoma in Colombia (Geno1.1-CLICaP) (2020)
 
19.- Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP) (2020)
 
20.- Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP) (2020)
 
21.- Multigene mutation profiling and clinical characteristics of small-cell lung cancer in never-smokers vs. Heavy smokers (GENO1.3-clicap) (2019)
 
22.- Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP) (2019)
 
23.- A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma (2019)
 
24.- Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib (2019)
 
25.- Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America (2019)
 
26.- Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices (2018)
 
27.- Probable hereditary familial overlap syndrome with multiple synchronous lung tumors (2018)
 
28.- EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP) (2018)
 
29.- EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP) (2018)
 
30.- The reality of complexity: Concomitant genomic alterations in patients with EGFR mutations (2018)
 
31.- Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma (2018)
 
32.- An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP) (2017)
 
33.- Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP) (2017)
 
34.- BIM deletion polymorphisms in Hispanic patients with non-small cell lung cancer carriers of EGFR mutations (2016)
 
35.- Pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab in Hispanic patients with non-squamous non-small cell lung cancer: Outcomes according to thymidylate synthase expression (2016)
 
36.- Genotyping low-grade gliomas among hispanics (2016)
 
37.- Novelties on amoebiasis: A neglected tropical disease (2011)
 
38.- The impact of improved wood-burning stoves on fine particulate matter concentrations in rural Mexican homes (2007)
 
39.- Dating of mineral samples through activation analysis of argon (1995)
 
40.- Insulin regulation of spermatozoa metabolism. (1973)
 
41.- Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019?Infected Patients With Lung Cancer ()
 
42.- Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP-LATimus) ()
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.